维普期刊资源整合服务平台（V6.5）

236篇 您的检索式：作者名="Bullinger"

选中清除导出查看参考文献查看引证文献引用追踪共12页首页上一页第1页下一页末页 /12 跳转

	题名	作者	年代	出处	被引量
1	美国大河能源公司煤克瑞克电厂模式显示文摘为了提高电厂发电能源效率,并提高电厂的经济效益,介绍美国大河能源公司煤克瑞克(CoalCreek)电厂利用电厂余热干燥褐煤,使褐煤热值从14.42 MJ/kg提高到16.51 MJ/kg用于发电,全厂发电能源效率提高3%~4%,污染物排放减少,SO2排放减少40%以上,汞排放减少40%以上,NOx排放减少30%以上,CO2排放减少4%,利用电厂的低压蒸汽生产加工附加值更高的饲料和乙醇,获得税前利润2.82千万美元。并对煤克瑞克电厂模式在我国的推广应用前景进行了分析。	张文辉 Charlie Bullinger	2015	洁净煤技术2015，21，6：	2
2	Identification of Gene Expression–Based Prognostic Markers in the Hematopoietic Stem Cells of Patients With Myelodysplastic Syndromes显示文摘	Andrea Pellagatti Axel Benner Ken I. Mills Mario Cazzola Aristoteles Giagounidis Janet Perry Luca Malcovati Matteo G. Della Porta Martin J?dersten Amit Verma Emma-Jane McDonald Sally Killick Eva Hellstr?m-Lindberg Lars Bullinger James S. Wainscoat Jacquel	2013	Journal of Clinical Oncology2013，，28：	2
3	Regional expression ofaquaporin 1,4, and 9 in the brain during pregnancy 显示文摘	Wiegman M J Bullinger LV Kohlmeyer MM	2008	Reprod Sci2008，15，5：	1
4	Community-based in- novation contests : where competition meets cooperation 显示文摘	Bullinger AC Neyer AK Rass M	2010	Creativity and Innovation Management2010，19，3：	1
5	Aberrant expression of miR-9/9^* in myeloid progenitors inhibits neutrophil differentiation by post-transcriptional regulation of ERG显示文摘	Nowek K Sun S M Bullinger L	2016	Leukemia2016，30，1：	1
6	The world health organization WHORL-100显示文摘	Power M Harper A Bullinger M	1999	Health Psychology1999，18，5：	1
7	AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias 显示文摘	Sykes SM Lane SW Bullinger L	2011	Cell2011，146，5：	1
8	AKT/FOXO signaling en-forces reversible differentiation blockade in myeloid leukemias显示文摘	Sykes S M Lane S W Bullinger L	2011	Cell2011，146，5：	1
9	An FL T3 gene-expression signature predicts clinical out?come in normal karyotype AML显示文摘	BULLINGER L DOHNER K KRANZ R	2008	Blood2008，111，：	1
10	AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias显示文摘	Sykes SM Lane SW Bullinger L		0，，：	1
11	Genetic and pharmacologic inhibition of beta-catenin targets imatinib-resistant leukemia stem cells in CML显示文摘	Heidel FH Bullinger L Feng Z	2012	Cell Stem Cell2012，10，4：	1
12	Community-based Innovation Contests:WhereCompetition Meets Cooperation显示文摘	Bullinger A C	2010	Creativity and Innovation Man- agement2010，19，3：	1
13	Compa- ring two measures of quality of life for children with hae- mophilia: the CHO-KLAT and the Haemo-QoL显示文摘	Bradley CS Bullinger M McCusker PJ	2006	Haemophilia2006，12，6：	1
14	A review of the progress towards developing health-related quality -of-life instruments for international clinical studies and outcomes research显示文摘	Anderson RT Aaronson NK Bullinger M	1996	Pharmacoeeonomics1996，10，4：	1
15	Genetics of chronic lymphocytic leukemia:genomic aberrations and V (H) gene mutation status in pathogenesis and clinical course显示文摘	Stilgenbauer S Bullinger L Lichter P	2002	Leukemia2002，16，6：	1
16	Community-based innovation con- tests:where competition meets cooperation显示文摘	BULLINGER A C	2010	Creativity and Innovation Management2010，19，3：	1
17	DNMT3A mutations in myeloproliferative neoplasms显示文摘	Stegelmann F Bullinger L Schlenk RF	2011	Leukemia2011，25，7：	1
18	Devel- opment and testing of an instrument to assess the Quality of Life of Children with Haemophilia in Europe (Haemo- QoL) 显示文摘	Mackensen S Bullinger M HAEMOQOL Group	2004	Haemophilia2004，10，1：	1
19	Psychological comorbidity in children and adolescents with chronic somatic diseases显示文摘	Erhart M Weimann A Bullinger M	2011	Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz2011，54，1：	1
20	RUNX1 mutations in acute myeloid leukemia: re- sults from a comprehensive genetic and clinical analy- sis from the AML study group显示文摘	GAIDZIK V I BULLINGER L SCHLENK R F	2011	J Clin Oncol2011，29，：	1

返回顶部每页显示：

共12页首页上一页第1页下一页末页 /12 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示